Negative Regulation of the Hippo Pathway by E3 Ubiquitin Ligase ITCH Is Sufficient to Promote Tumorigenicity

被引:119
|
作者
Salah, Zaidoun [1 ]
Melino, Gerry [2 ]
Aqeilan, Rami I. [1 ]
机构
[1] Hebrew Univ Jerusalem, Hadassah Med Sch, Lautenberg Ctr Immunol & Canc Res, IMRIC, IL-91120 Jerusalem, Israel
[2] Univ Leicester, MRC Toxicol Unit, Leicester, Leics, England
关键词
PUTATIVE TUMOR-SUPPRESSOR; DOWN-REGULATION; TEAD/TEF FAMILY; PROTEIN LIGASE; SIZE-CONTROL; LATS1; YAP; P73; GROWTH; MST2;
D O I
10.1158/0008-5472.CAN-10-3516
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
The Hippo tumor suppressor pathway, originally defined in fruit flies, regulates cellular proliferation and survival and exerts profound effects on normal mammalian cell fate and tumorigenesis. The present understanding of Hippo pathway components and mechanisms remains incomplete in cancer. WW domaincontaining proteins regulate diverse biological processes through interaction with proline-tyrosine (PPxY)-containing targets. In this study, we report that the E3 ubiquitin ligase ITCH regulates stability of LATS1, a serine/threonine kinase in the Hippo pathway, through protein-protein interaction of the PPxY motifs of LATS1 with the WW domains of ITCH. Ubiquitination of LATS1 catalyzed by ITCH stimulated the proteasomal degradation of LATS1. Furthermore, ITCH-mediated degradation of LATS1 was associated with enhanced cell growth, induction of epithelial-mesenchymal transition, and increased tumorigenicity. Conversely, ITCH depletion increased LATS1 levels, enhancing FAS-induced apoptosis and reducing proliferation, survival, and migration. These phenotypes were rescued when both ITCH and LATS1 were depleted. Together, our results reveal a novel functional link between ITCH and the Hippo pathway, deepening their critical roles in tumorigenesis. Cancer Res; 71(5); 2010-20. (c) 2011 AACR.
引用
收藏
页码:2010 / 2020
页数:11
相关论文
共 50 条
  • [1] Negative regulation of the Hippo pathway by the E3 ubiquitin ligase ITCH promotes tumorigenicity
    Salah, Zaidoun
    Melino, Gerry
    Aqeilan, Rami
    CANCER RESEARCH, 2011, 71
  • [2] Negative Regulation of the Hippo Pathway by E3 Ubiquitin Ligase ITCH Is Sufficient to Promote Tumorigenicity (vol 71, pg 2010, 2011)
    Salah, Zaidoun
    Melino, Gerry
    Aqeilan, Rami I.
    CANCER RESEARCH, 2019, 79 (11) : 3007 - 3007
  • [3] Regulation of autoimmune disease by the E3 ubiquitin ligase Itch
    Moser, Emily K.
    Oliver, Paula M.
    CELLULAR IMMUNOLOGY, 2019, 340
  • [4] The ubiquitin E3 ligase ITCH enhances breast tumor progression by inhibiting the Hippo tumor suppressor pathway
    Salah, Zaidoun
    Itzhaki, Ella
    Aqeilan, Rami I.
    ONCOTARGET, 2014, 5 (21) : 10886 - 10900
  • [5] Negative regulation of the E3 ubiquitin ligase itch via Fyn-mediated tyrosine phosphorylation
    Yang, C
    Zhou, WD
    Jeon, MS
    Demydenko, D
    Harada, Y
    Zhou, HL
    Liu, YC
    MOLECULAR CELL, 2006, 21 (01) : 135 - 141
  • [6] MITOCHONDRIAL DYSFUNCTION IN ITCH E3 UBIQUITIN LIGASE DEFICIENCY
    Gonzalez, Lina Ghaloul
    Wolfe, Rachel
    Mohsen, Al-Walid
    Vockley, Jerry
    MOLECULAR GENETICS AND METABOLISM, 2019, 127 (03) : 271 - 271
  • [7] Regulation of T Cell Differentiation and Allergic Responses by the E3 Ubiquitin Ligase Itch
    Liu, Y. -C.
    UBIQUITIN SYSTEM IN HEALTH AND DISEASE, 2009, 1 : 137 - 152
  • [8] MITOCHONDRIAL DYSFUNCTION IN ITCH E3 UBIQUITIN LIGASE DEFICIENCY
    Gonzalez, Lina Ghaloul
    Wolfe, Rachel
    Mohsen, Al-Walid
    Vockley, Jerry
    MOLECULAR GENETICS AND METABOLISM, 2019, 126 (03) : 303 - 303
  • [9] The E3 ligase Itch in immune regulation and beyond
    Aki, Daisuke
    Zhang, Wen
    Liu, Yun-Cai
    IMMUNOLOGICAL REVIEWS, 2015, 266 (01) : 6 - 26
  • [10] Itch, an E3 ubiquitin ligase, is a new target for nonalcoholic steatohepatitis
    Marino, A.
    Cardellini, M.
    Menghini, R.
    Davato, F.
    Peschiaroli, A.
    Sbraccia, P.
    Gentileschi, P.
    Melino, G.
    Lauro, R.
    Federici, M.
    DIABETOLOGIA, 2012, 55 : S264 - S265